Pharma & Healthcare
Global Nifedipine Extended Release Tablets Market Research Report 2025
- Sep 24, 25
- ID: 523512
- Pages: 100
- Figures: 105
- Views: 6
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nifedipine Extended Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine Extended Release Tablets.
The Nifedipine Extended Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine Extended Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nifedipine Extended Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Valeant Pharmaceuticals
Zydus Pharmaceuticals Inc
Aurobindo Pharma LTD
Pfizer Inc
Sun Pharma Industries LTD
Osmotica Pharmaceuticals
Alkem Laboratories Ltd.
Novast Novast Laboratories, LTD
TWi Pharmaceuticals Inc.
Shyndec Pharmaceutical Co., Ltd
China National Pharmaceutical Industry Co., Ltd
China Resource Pharmaceutical Group Co., Ltd
Anglikang Pharmaceutical Co., Ltd
Warrant Chiral Pharmaceutical Co., Ltd
Tailison Pharmaceutical Co., Ltd
Baheal Medical Inc.
Bocheng Pharmaceutical Co., Ltd
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nifedipine Extended Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nifedipine Extended Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Nifedipine Extended Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine Extended Release Tablets.
The Nifedipine Extended Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine Extended Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nifedipine Extended Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Valeant Pharmaceuticals
Zydus Pharmaceuticals Inc
Aurobindo Pharma LTD
Pfizer Inc
Sun Pharma Industries LTD
Osmotica Pharmaceuticals
Alkem Laboratories Ltd.
Novast Novast Laboratories, LTD
TWi Pharmaceuticals Inc.
Shyndec Pharmaceutical Co., Ltd
China National Pharmaceutical Industry Co., Ltd
China Resource Pharmaceutical Group Co., Ltd
Anglikang Pharmaceutical Co., Ltd
Warrant Chiral Pharmaceutical Co., Ltd
Tailison Pharmaceutical Co., Ltd
Baheal Medical Inc.
Bocheng Pharmaceutical Co., Ltd
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nifedipine Extended Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nifedipine Extended Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Nifedipine Extended Release Tablets Market Overview
1.1 Product Definition
1.2 Nifedipine Extended Release Tablets by Type
1.2.1 Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Nifedipine Extended Release Tablets by Application
1.3.1 Global Nifedipine Extended Release Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Nifedipine Extended Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Extended Release Tablets Revenue 2020-2031
1.4.2 Global Nifedipine Extended Release Tablets Sales 2020-2031
1.4.3 Global Nifedipine Extended Release Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nifedipine Extended Release Tablets Market Competition by Manufacturers
2.1 Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nifedipine Extended Release Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nifedipine Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nifedipine Extended Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nifedipine Extended Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Nifedipine Extended Release Tablets, Date of Enter into This Industry
2.8 Global Nifedipine Extended Release Tablets Market Competitive Situation and Trends
2.8.1 Global Nifedipine Extended Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nifedipine Extended Release Tablets Players Market Share by Revenue
2.8.3 Global Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Extended Release Tablets Market Scenario by Region
3.1 Global Nifedipine Extended Release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nifedipine Extended Release Tablets Sales by Region: 2020-2031
3.2.1 Global Nifedipine Extended Release Tablets Sales by Region: 2020-2025
3.2.2 Global Nifedipine Extended Release Tablets Sales by Region: 2026-2031
3.3 Global Nifedipine Extended Release Tablets Revenue by Region: 2020-2031
3.3.1 Global Nifedipine Extended Release Tablets Revenue by Region: 2020-2025
3.3.2 Global Nifedipine Extended Release Tablets Revenue by Region: 2026-2031
3.4 North America Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.4.1 North America Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.4.3 North America Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.5.1 Europe Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.5.3 Europe Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Extended Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Extended Release Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.7.3 Latin America Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine Extended Release Tablets Sales by Type (2020-2031)
4.1.1 Global Nifedipine Extended Release Tablets Sales by Type (2020-2025)
4.1.2 Global Nifedipine Extended Release Tablets Sales by Type (2026-2031)
4.1.3 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2031)
4.2 Global Nifedipine Extended Release Tablets Revenue by Type (2020-2031)
4.2.1 Global Nifedipine Extended Release Tablets Revenue by Type (2020-2025)
4.2.2 Global Nifedipine Extended Release Tablets Revenue by Type (2026-2031)
4.2.3 Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Nifedipine Extended Release Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nifedipine Extended Release Tablets Sales by Application (2020-2031)
5.1.1 Global Nifedipine Extended Release Tablets Sales by Application (2020-2025)
5.1.2 Global Nifedipine Extended Release Tablets Sales by Application (2026-2031)
5.1.3 Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2031)
5.2 Global Nifedipine Extended Release Tablets Revenue by Application (2020-2031)
5.2.1 Global Nifedipine Extended Release Tablets Revenue by Application (2020-2025)
5.2.2 Global Nifedipine Extended Release Tablets Revenue by Application (2026-2031)
5.2.3 Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Nifedipine Extended Release Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Valeant Pharmaceuticals
6.1.1 Valeant Pharmaceuticals Company Information
6.1.2 Valeant Pharmaceuticals Description and Business Overview
6.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolio
6.1.5 Valeant Pharmaceuticals Recent Developments/Updates
6.2 Zydus Pharmaceuticals Inc
6.2.1 Zydus Pharmaceuticals Inc Company Information
6.2.2 Zydus Pharmaceuticals Inc Description and Business Overview
6.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolio
6.2.5 Zydus Pharmaceuticals Inc Recent Developments/Updates
6.3 Aurobindo Pharma LTD
6.3.1 Aurobindo Pharma LTD Company Information
6.3.2 Aurobindo Pharma LTD Description and Business Overview
6.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolio
6.3.5 Aurobindo Pharma LTD Recent Developments/Updates
6.4 Pfizer Inc
6.4.1 Pfizer Inc Company Information
6.4.2 Pfizer Inc Description and Business Overview
6.4.3 Pfizer Inc Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Inc Nifedipine Extended Release Tablets Product Portfolio
6.4.5 Pfizer Inc Recent Developments/Updates
6.5 Sun Pharma Industries LTD
6.5.1 Sun Pharma Industries LTD Company Information
6.5.2 Sun Pharma Industries LTD Description and Business Overview
6.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolio
6.5.5 Sun Pharma Industries LTD Recent Developments/Updates
6.6 Osmotica Pharmaceuticals
6.6.1 Osmotica Pharmaceuticals Company Information
6.6.2 Osmotica Pharmaceuticals Description and Business Overview
6.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolio
6.6.5 Osmotica Pharmaceuticals Recent Developments/Updates
6.7 Alkem Laboratories Ltd.
6.7.1 Alkem Laboratories Ltd. Company Information
6.7.2 Alkem Laboratories Ltd. Description and Business Overview
6.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolio
6.7.5 Alkem Laboratories Ltd. Recent Developments/Updates
6.8 Novast Novast Laboratories, LTD
6.8.1 Novast Novast Laboratories, LTD Company Information
6.8.2 Novast Novast Laboratories, LTD Description and Business Overview
6.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolio
6.8.5 Novast Novast Laboratories, LTD Recent Developments/Updates
6.9 TWi Pharmaceuticals Inc.
6.9.1 TWi Pharmaceuticals Inc. Company Information
6.9.2 TWi Pharmaceuticals Inc. Description and Business Overview
6.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolio
6.9.5 TWi Pharmaceuticals Inc. Recent Developments/Updates
6.10 Shyndec Pharmaceutical Co., Ltd
6.10.1 Shyndec Pharmaceutical Co., Ltd Company Information
6.10.2 Shyndec Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.10.5 Shyndec Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 China National Pharmaceutical Industry Co., Ltd
6.11.1 China National Pharmaceutical Industry Co., Ltd Company Information
6.11.2 China National Pharmaceutical Industry Co., Ltd Description and Business Overview
6.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.11.5 China National Pharmaceutical Industry Co., Ltd Recent Developments/Updates
6.12 China Resource Pharmaceutical Group Co., Ltd
6.12.1 China Resource Pharmaceutical Group Co., Ltd Company Information
6.12.2 China Resource Pharmaceutical Group Co., Ltd Description and Business Overview
6.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.12.5 China Resource Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.13 Anglikang Pharmaceutical Co., Ltd
6.13.1 Anglikang Pharmaceutical Co., Ltd Company Information
6.13.2 Anglikang Pharmaceutical Co., Ltd Description and Business Overview
6.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.13.5 Anglikang Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Warrant Chiral Pharmaceutical Co., Ltd
6.14.1 Warrant Chiral Pharmaceutical Co., Ltd Company Information
6.14.2 Warrant Chiral Pharmaceutical Co., Ltd Description and Business Overview
6.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.14.5 Warrant Chiral Pharmaceutical Co., Ltd Recent Developments/Updates
6.15 Tailison Pharmaceutical Co., Ltd
6.15.1 Tailison Pharmaceutical Co., Ltd Company Information
6.15.2 Tailison Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.15.5 Tailison Pharmaceutical Co., Ltd Recent Developments/Updates
6.16 Baheal Medical Inc.
6.16.1 Baheal Medical Inc. Company Information
6.16.2 Baheal Medical Inc. Description and Business Overview
6.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolio
6.16.5 Baheal Medical Inc. Recent Developments/Updates
6.17 Bocheng Pharmaceutical Co., Ltd
6.17.1 Bocheng Pharmaceutical Co., Ltd Company Information
6.17.2 Bocheng Pharmaceutical Co., Ltd Description and Business Overview
6.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.17.5 Bocheng Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Extended Release Tablets Industry Chain Analysis
7.2 Nifedipine Extended Release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Extended Release Tablets Production Mode & Process Analysis
7.4 Nifedipine Extended Release Tablets Sales and Marketing
7.4.1 Nifedipine Extended Release Tablets Sales Channels
7.4.2 Nifedipine Extended Release Tablets Distributors
7.5 Nifedipine Extended Release Tablets Customer Analysis
8 Nifedipine Extended Release Tablets Market Dynamics
8.1 Nifedipine Extended Release Tablets Industry Trends
8.2 Nifedipine Extended Release Tablets Market Drivers
8.3 Nifedipine Extended Release Tablets Market Challenges
8.4 Nifedipine Extended Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Nifedipine Extended Release Tablets by Type
1.2.1 Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Nifedipine Extended Release Tablets by Application
1.3.1 Global Nifedipine Extended Release Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Nifedipine Extended Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Extended Release Tablets Revenue 2020-2031
1.4.2 Global Nifedipine Extended Release Tablets Sales 2020-2031
1.4.3 Global Nifedipine Extended Release Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nifedipine Extended Release Tablets Market Competition by Manufacturers
2.1 Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nifedipine Extended Release Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nifedipine Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nifedipine Extended Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nifedipine Extended Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Nifedipine Extended Release Tablets, Date of Enter into This Industry
2.8 Global Nifedipine Extended Release Tablets Market Competitive Situation and Trends
2.8.1 Global Nifedipine Extended Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nifedipine Extended Release Tablets Players Market Share by Revenue
2.8.3 Global Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Extended Release Tablets Market Scenario by Region
3.1 Global Nifedipine Extended Release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nifedipine Extended Release Tablets Sales by Region: 2020-2031
3.2.1 Global Nifedipine Extended Release Tablets Sales by Region: 2020-2025
3.2.2 Global Nifedipine Extended Release Tablets Sales by Region: 2026-2031
3.3 Global Nifedipine Extended Release Tablets Revenue by Region: 2020-2031
3.3.1 Global Nifedipine Extended Release Tablets Revenue by Region: 2020-2025
3.3.2 Global Nifedipine Extended Release Tablets Revenue by Region: 2026-2031
3.4 North America Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.4.1 North America Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.4.3 North America Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.5.1 Europe Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.5.3 Europe Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Extended Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Extended Release Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.7.3 Latin America Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nifedipine Extended Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine Extended Release Tablets Sales by Type (2020-2031)
4.1.1 Global Nifedipine Extended Release Tablets Sales by Type (2020-2025)
4.1.2 Global Nifedipine Extended Release Tablets Sales by Type (2026-2031)
4.1.3 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2031)
4.2 Global Nifedipine Extended Release Tablets Revenue by Type (2020-2031)
4.2.1 Global Nifedipine Extended Release Tablets Revenue by Type (2020-2025)
4.2.2 Global Nifedipine Extended Release Tablets Revenue by Type (2026-2031)
4.2.3 Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Nifedipine Extended Release Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nifedipine Extended Release Tablets Sales by Application (2020-2031)
5.1.1 Global Nifedipine Extended Release Tablets Sales by Application (2020-2025)
5.1.2 Global Nifedipine Extended Release Tablets Sales by Application (2026-2031)
5.1.3 Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2031)
5.2 Global Nifedipine Extended Release Tablets Revenue by Application (2020-2031)
5.2.1 Global Nifedipine Extended Release Tablets Revenue by Application (2020-2025)
5.2.2 Global Nifedipine Extended Release Tablets Revenue by Application (2026-2031)
5.2.3 Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Nifedipine Extended Release Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Valeant Pharmaceuticals
6.1.1 Valeant Pharmaceuticals Company Information
6.1.2 Valeant Pharmaceuticals Description and Business Overview
6.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolio
6.1.5 Valeant Pharmaceuticals Recent Developments/Updates
6.2 Zydus Pharmaceuticals Inc
6.2.1 Zydus Pharmaceuticals Inc Company Information
6.2.2 Zydus Pharmaceuticals Inc Description and Business Overview
6.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolio
6.2.5 Zydus Pharmaceuticals Inc Recent Developments/Updates
6.3 Aurobindo Pharma LTD
6.3.1 Aurobindo Pharma LTD Company Information
6.3.2 Aurobindo Pharma LTD Description and Business Overview
6.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolio
6.3.5 Aurobindo Pharma LTD Recent Developments/Updates
6.4 Pfizer Inc
6.4.1 Pfizer Inc Company Information
6.4.2 Pfizer Inc Description and Business Overview
6.4.3 Pfizer Inc Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Inc Nifedipine Extended Release Tablets Product Portfolio
6.4.5 Pfizer Inc Recent Developments/Updates
6.5 Sun Pharma Industries LTD
6.5.1 Sun Pharma Industries LTD Company Information
6.5.2 Sun Pharma Industries LTD Description and Business Overview
6.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolio
6.5.5 Sun Pharma Industries LTD Recent Developments/Updates
6.6 Osmotica Pharmaceuticals
6.6.1 Osmotica Pharmaceuticals Company Information
6.6.2 Osmotica Pharmaceuticals Description and Business Overview
6.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolio
6.6.5 Osmotica Pharmaceuticals Recent Developments/Updates
6.7 Alkem Laboratories Ltd.
6.7.1 Alkem Laboratories Ltd. Company Information
6.7.2 Alkem Laboratories Ltd. Description and Business Overview
6.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolio
6.7.5 Alkem Laboratories Ltd. Recent Developments/Updates
6.8 Novast Novast Laboratories, LTD
6.8.1 Novast Novast Laboratories, LTD Company Information
6.8.2 Novast Novast Laboratories, LTD Description and Business Overview
6.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolio
6.8.5 Novast Novast Laboratories, LTD Recent Developments/Updates
6.9 TWi Pharmaceuticals Inc.
6.9.1 TWi Pharmaceuticals Inc. Company Information
6.9.2 TWi Pharmaceuticals Inc. Description and Business Overview
6.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolio
6.9.5 TWi Pharmaceuticals Inc. Recent Developments/Updates
6.10 Shyndec Pharmaceutical Co., Ltd
6.10.1 Shyndec Pharmaceutical Co., Ltd Company Information
6.10.2 Shyndec Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.10.5 Shyndec Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 China National Pharmaceutical Industry Co., Ltd
6.11.1 China National Pharmaceutical Industry Co., Ltd Company Information
6.11.2 China National Pharmaceutical Industry Co., Ltd Description and Business Overview
6.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.11.5 China National Pharmaceutical Industry Co., Ltd Recent Developments/Updates
6.12 China Resource Pharmaceutical Group Co., Ltd
6.12.1 China Resource Pharmaceutical Group Co., Ltd Company Information
6.12.2 China Resource Pharmaceutical Group Co., Ltd Description and Business Overview
6.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.12.5 China Resource Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.13 Anglikang Pharmaceutical Co., Ltd
6.13.1 Anglikang Pharmaceutical Co., Ltd Company Information
6.13.2 Anglikang Pharmaceutical Co., Ltd Description and Business Overview
6.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.13.5 Anglikang Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Warrant Chiral Pharmaceutical Co., Ltd
6.14.1 Warrant Chiral Pharmaceutical Co., Ltd Company Information
6.14.2 Warrant Chiral Pharmaceutical Co., Ltd Description and Business Overview
6.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.14.5 Warrant Chiral Pharmaceutical Co., Ltd Recent Developments/Updates
6.15 Tailison Pharmaceutical Co., Ltd
6.15.1 Tailison Pharmaceutical Co., Ltd Company Information
6.15.2 Tailison Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.15.5 Tailison Pharmaceutical Co., Ltd Recent Developments/Updates
6.16 Baheal Medical Inc.
6.16.1 Baheal Medical Inc. Company Information
6.16.2 Baheal Medical Inc. Description and Business Overview
6.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolio
6.16.5 Baheal Medical Inc. Recent Developments/Updates
6.17 Bocheng Pharmaceutical Co., Ltd
6.17.1 Bocheng Pharmaceutical Co., Ltd Company Information
6.17.2 Bocheng Pharmaceutical Co., Ltd Description and Business Overview
6.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio
6.17.5 Bocheng Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Extended Release Tablets Industry Chain Analysis
7.2 Nifedipine Extended Release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Extended Release Tablets Production Mode & Process Analysis
7.4 Nifedipine Extended Release Tablets Sales and Marketing
7.4.1 Nifedipine Extended Release Tablets Sales Channels
7.4.2 Nifedipine Extended Release Tablets Distributors
7.5 Nifedipine Extended Release Tablets Customer Analysis
8 Nifedipine Extended Release Tablets Market Dynamics
8.1 Nifedipine Extended Release Tablets Industry Trends
8.2 Nifedipine Extended Release Tablets Market Drivers
8.3 Nifedipine Extended Release Tablets Market Challenges
8.4 Nifedipine Extended Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nifedipine Extended Release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nifedipine Extended Release Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nifedipine Extended Release Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nifedipine Extended Release Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nifedipine Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nifedipine Extended Release Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nifedipine Extended Release Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Nifedipine Extended Release Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nifedipine Extended Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Extended Release Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nifedipine Extended Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Nifedipine Extended Release Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Nifedipine Extended Release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Nifedipine Extended Release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nifedipine Extended Release Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Nifedipine Extended Release Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nifedipine Extended Release Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Nifedipine Extended Release Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Valeant Pharmaceuticals Company Information
Table 71. Valeant Pharmaceuticals Description and Business Overview
Table 72. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product
Table 74. Valeant Pharmaceuticals Recent Developments/Updates
Table 75. Zydus Pharmaceuticals Inc Company Information
Table 76. Zydus Pharmaceuticals Inc Description and Business Overview
Table 77. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product
Table 79. Zydus Pharmaceuticals Inc Recent Developments/Updates
Table 80. Aurobindo Pharma LTD Company Information
Table 81. Aurobindo Pharma LTD Description and Business Overview
Table 82. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product
Table 84. Aurobindo Pharma LTD Recent Developments/Updates
Table 85. Pfizer Inc Company Information
Table 86. Pfizer Inc Description and Business Overview
Table 87. Pfizer Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Inc Nifedipine Extended Release Tablets Product
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Sun Pharma Industries LTD Company Information
Table 91. Sun Pharma Industries LTD Description and Business Overview
Table 92. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product
Table 94. Sun Pharma Industries LTD Recent Developments/Updates
Table 95. Osmotica Pharmaceuticals Company Information
Table 96. Osmotica Pharmaceuticals Description and Business Overview
Table 97. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product
Table 99. Osmotica Pharmaceuticals Recent Developments/Updates
Table 100. Alkem Laboratories Ltd. Company Information
Table 101. Alkem Laboratories Ltd. Description and Business Overview
Table 102. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product
Table 104. Alkem Laboratories Ltd. Recent Developments/Updates
Table 105. Novast Novast Laboratories, LTD Company Information
Table 106. Novast Novast Laboratories, LTD Description and Business Overview
Table 107. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product
Table 109. Novast Novast Laboratories, LTD Recent Developments/Updates
Table 110. TWi Pharmaceuticals Inc. Company Information
Table 111. TWi Pharmaceuticals Inc. Description and Business Overview
Table 112. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product
Table 114. TWi Pharmaceuticals Inc. Recent Developments/Updates
Table 115. Shyndec Pharmaceutical Co., Ltd Company Information
Table 116. Shyndec Pharmaceutical Co., Ltd Description and Business Overview
Table 117. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 119. Shyndec Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. China National Pharmaceutical Industry Co., Ltd Company Information
Table 121. China National Pharmaceutical Industry Co., Ltd Description and Business Overview
Table 122. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product
Table 124. China National Pharmaceutical Industry Co., Ltd Recent Developments/Updates
Table 125. China Resource Pharmaceutical Group Co., Ltd Company Information
Table 126. China Resource Pharmaceutical Group Co., Ltd Description and Business Overview
Table 127. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product
Table 129. China Resource Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 130. Anglikang Pharmaceutical Co., Ltd Company Information
Table 131. Anglikang Pharmaceutical Co., Ltd Description and Business Overview
Table 132. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 134. Anglikang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 135. Warrant Chiral Pharmaceutical Co., Ltd Company Information
Table 136. Warrant Chiral Pharmaceutical Co., Ltd Description and Business Overview
Table 137. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 139. Warrant Chiral Pharmaceutical Co., Ltd Recent Developments/Updates
Table 140. Tailison Pharmaceutical Co., Ltd Company Information
Table 141. Tailison Pharmaceutical Co., Ltd Description and Business Overview
Table 142. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 144. Tailison Pharmaceutical Co., Ltd Recent Developments/Updates
Table 145. Baheal Medical Inc. Company Information
Table 146. Baheal Medical Inc. Description and Business Overview
Table 147. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Baheal Medical Inc. Nifedipine Extended Release Tablets Product
Table 149. Baheal Medical Inc. Recent Developments/Updates
Table 150. Bocheng Pharmaceutical Co., Ltd Company Information
Table 151. Bocheng Pharmaceutical Co., Ltd Description and Business Overview
Table 152. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 154. Bocheng Pharmaceutical Co., Ltd Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Nifedipine Extended Release Tablets Distributors List
Table 158. Nifedipine Extended Release Tablets Customers List
Table 159. Nifedipine Extended Release Tablets Market Trends
Table 160. Nifedipine Extended Release Tablets Market Drivers
Table 161. Nifedipine Extended Release Tablets Market Challenges
Table 162. Nifedipine Extended Release Tablets Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nifedipine Extended Release Tablets
Figure 2. Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nifedipine Extended Release Tablets Market Share by Type: 2024 & 2031
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Nifedipine Extended Release Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Nifedipine Extended Release Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Others
Figure 11. Global Nifedipine Extended Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Nifedipine Extended Release Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Nifedipine Extended Release Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Nifedipine Extended Release Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Nifedipine Extended Release Tablets Report Years Considered
Figure 16. Nifedipine Extended Release Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Nifedipine Extended Release Tablets Players: Market Share by Revenue in Nifedipine Extended Release Tablets in 2024
Figure 19. Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Nifedipine Extended Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Nifedipine Extended Release Tablets by Type (2020-2031)
Figure 52. Global Revenue Market Share of Nifedipine Extended Release Tablets by Type (2020-2031)
Figure 53. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Nifedipine Extended Release Tablets by Application (2020-2031)
Figure 55. Global Revenue Market Share of Nifedipine Extended Release Tablets by Application (2020-2031)
Figure 56. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2020-2031)
Figure 57. Nifedipine Extended Release Tablets Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nifedipine Extended Release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nifedipine Extended Release Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nifedipine Extended Release Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nifedipine Extended Release Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nifedipine Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nifedipine Extended Release Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nifedipine Extended Release Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Nifedipine Extended Release Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nifedipine Extended Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Extended Release Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nifedipine Extended Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Nifedipine Extended Release Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Nifedipine Extended Release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Nifedipine Extended Release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nifedipine Extended Release Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Nifedipine Extended Release Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nifedipine Extended Release Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Nifedipine Extended Release Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Valeant Pharmaceuticals Company Information
Table 71. Valeant Pharmaceuticals Description and Business Overview
Table 72. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product
Table 74. Valeant Pharmaceuticals Recent Developments/Updates
Table 75. Zydus Pharmaceuticals Inc Company Information
Table 76. Zydus Pharmaceuticals Inc Description and Business Overview
Table 77. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product
Table 79. Zydus Pharmaceuticals Inc Recent Developments/Updates
Table 80. Aurobindo Pharma LTD Company Information
Table 81. Aurobindo Pharma LTD Description and Business Overview
Table 82. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product
Table 84. Aurobindo Pharma LTD Recent Developments/Updates
Table 85. Pfizer Inc Company Information
Table 86. Pfizer Inc Description and Business Overview
Table 87. Pfizer Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Inc Nifedipine Extended Release Tablets Product
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Sun Pharma Industries LTD Company Information
Table 91. Sun Pharma Industries LTD Description and Business Overview
Table 92. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product
Table 94. Sun Pharma Industries LTD Recent Developments/Updates
Table 95. Osmotica Pharmaceuticals Company Information
Table 96. Osmotica Pharmaceuticals Description and Business Overview
Table 97. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product
Table 99. Osmotica Pharmaceuticals Recent Developments/Updates
Table 100. Alkem Laboratories Ltd. Company Information
Table 101. Alkem Laboratories Ltd. Description and Business Overview
Table 102. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product
Table 104. Alkem Laboratories Ltd. Recent Developments/Updates
Table 105. Novast Novast Laboratories, LTD Company Information
Table 106. Novast Novast Laboratories, LTD Description and Business Overview
Table 107. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product
Table 109. Novast Novast Laboratories, LTD Recent Developments/Updates
Table 110. TWi Pharmaceuticals Inc. Company Information
Table 111. TWi Pharmaceuticals Inc. Description and Business Overview
Table 112. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product
Table 114. TWi Pharmaceuticals Inc. Recent Developments/Updates
Table 115. Shyndec Pharmaceutical Co., Ltd Company Information
Table 116. Shyndec Pharmaceutical Co., Ltd Description and Business Overview
Table 117. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 119. Shyndec Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. China National Pharmaceutical Industry Co., Ltd Company Information
Table 121. China National Pharmaceutical Industry Co., Ltd Description and Business Overview
Table 122. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product
Table 124. China National Pharmaceutical Industry Co., Ltd Recent Developments/Updates
Table 125. China Resource Pharmaceutical Group Co., Ltd Company Information
Table 126. China Resource Pharmaceutical Group Co., Ltd Description and Business Overview
Table 127. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product
Table 129. China Resource Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 130. Anglikang Pharmaceutical Co., Ltd Company Information
Table 131. Anglikang Pharmaceutical Co., Ltd Description and Business Overview
Table 132. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 134. Anglikang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 135. Warrant Chiral Pharmaceutical Co., Ltd Company Information
Table 136. Warrant Chiral Pharmaceutical Co., Ltd Description and Business Overview
Table 137. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 139. Warrant Chiral Pharmaceutical Co., Ltd Recent Developments/Updates
Table 140. Tailison Pharmaceutical Co., Ltd Company Information
Table 141. Tailison Pharmaceutical Co., Ltd Description and Business Overview
Table 142. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 144. Tailison Pharmaceutical Co., Ltd Recent Developments/Updates
Table 145. Baheal Medical Inc. Company Information
Table 146. Baheal Medical Inc. Description and Business Overview
Table 147. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Baheal Medical Inc. Nifedipine Extended Release Tablets Product
Table 149. Baheal Medical Inc. Recent Developments/Updates
Table 150. Bocheng Pharmaceutical Co., Ltd Company Information
Table 151. Bocheng Pharmaceutical Co., Ltd Description and Business Overview
Table 152. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product
Table 154. Bocheng Pharmaceutical Co., Ltd Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Nifedipine Extended Release Tablets Distributors List
Table 158. Nifedipine Extended Release Tablets Customers List
Table 159. Nifedipine Extended Release Tablets Market Trends
Table 160. Nifedipine Extended Release Tablets Market Drivers
Table 161. Nifedipine Extended Release Tablets Market Challenges
Table 162. Nifedipine Extended Release Tablets Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nifedipine Extended Release Tablets
Figure 2. Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nifedipine Extended Release Tablets Market Share by Type: 2024 & 2031
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Nifedipine Extended Release Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Nifedipine Extended Release Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Others
Figure 11. Global Nifedipine Extended Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Nifedipine Extended Release Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Nifedipine Extended Release Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Nifedipine Extended Release Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Nifedipine Extended Release Tablets Report Years Considered
Figure 16. Nifedipine Extended Release Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Nifedipine Extended Release Tablets Players: Market Share by Revenue in Nifedipine Extended Release Tablets in 2024
Figure 19. Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Nifedipine Extended Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Nifedipine Extended Release Tablets by Type (2020-2031)
Figure 52. Global Revenue Market Share of Nifedipine Extended Release Tablets by Type (2020-2031)
Figure 53. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Nifedipine Extended Release Tablets by Application (2020-2031)
Figure 55. Global Revenue Market Share of Nifedipine Extended Release Tablets by Application (2020-2031)
Figure 56. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2020-2031)
Figure 57. Nifedipine Extended Release Tablets Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232